Utpal Koppikar C4 Therapeutics, Inc. (CCCC) insider trading activity

CCCC Quotes by TradingView

Utpal Koppikar is Director of C4 Therapeutics, Inc.. Currently has a direct ownership of 5,667 shares of CCCC, which is worth approximately $25,104. The most recent transaction as insider was on Feb 08, 2023, when has been sold 5,667 shares (Common Stock) at a price of $5.6 per share, resulting in proceeds of $31,735. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.67K
0% 3M change
0% 12M change
Total Value Held $25,104

Utpal Koppikar Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 08 2023
BUY
Open market or private purchase
$31,735 $5.6 p/Share
5,667 Added 50.0%
5,667 Common Stock

Also insider at

ATRA
Atara Biotherapeutics, Inc. Healthcare
Chief Financial Officer
FLXN
Flexion Therapeutics Inc
Director
UK

Utpal Koppikar

Director
South San Francisco, CA

Track Institutional and Insider Activities on CCCC

Follow C4 Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CCCC shares.

Notify only if

Insider Trading

Get notified when an C4 Therapeutics, Inc. insider buys or sells CCCC shares.

Notify only if

News

Receive news related to C4 Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CCCC